Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Reference is made to the stock exchange notification of 27 May 2008 regarding the demerger of Photocure ASA with PCI Biotech Holding ASA as the acquiring company.
Completion of the demerger implies that all shareholders in Photocure will receive one share in PCI Biotech Holding for each share owned in Photocure. However, the PCI Biotech Holding shares will be subject to a reverse split in a 10:1 ratio prior to delivery. It is expected that the demerger will be registered as completed in the Register of Business Enterprises after end of trading today. It is expected that the Photocure shares will be traded first day exclusive of the right to receive shares in PCI Biotech Holding tomorrow, 17 June 2008. A stock exchange notification confirming this will be issued within start of trading tomorrow.
After the implementation of the demerger and simultaneous capitalization issue, Photocure's share capital will be NOK 11,046,650.50 divided on 22,093,301 shares, each with a nominal value of NOK 0.50.
